Thank you to all Alphas who participate in research studies that bring us closer to finding a cure. Patients are crucial for clinical trials as their participation helps researchers evaluate the safety and efficacy of new treatments leading to advancements in medical science and potentially breakthroughs in disease management for Alpha-1 Antitrypsin Deficiency (Alpha-1).
Actively Enrolling Clinical Trials
Click below to learn more about clinical trial opportunities available today:
The Redwood Study also known as TAK-999-3001, sponsored by Takeda, is researching an investigational study drug for Alpha-1 Liver Disease.
Be Part of the Pathway to a Cure
By joining the Alpha-1 Research Registry, you will learn first-hand about clinical trials you may qualify for and other clinical research opportunities.
To enroll in the Alpha-1 Research Registry, click here.
If you would like to learn more about research and clinical trial opportunities, contact the Alpha-1 Foundation by email at alpha1registry@alpha1.org or telephone at 1-877-228-7321 ext. 252 or 245.
